IDROXOCOBALAMINA Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

idroxocobalamina

pharminvest spa - idrossocobalamina - idrossocobalamina

XEOMIN, incobotulinumtoxinA, 100  units; purified neurotoxin, free from complexing proteins Australia - engelsk - Department of Health (Therapeutic Goods Administration)

xeomin, incobotulinumtoxina, 100 units; purified neurotoxin, free from complexing proteins

merz australia pty ltd - incobotulinumtoxina, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins Australia - engelsk - Department of Health (Therapeutic Goods Administration)

xeomin, incobotulinumtoxina, 50 units; purified neurotoxin, free from complexing proteins

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

CYANOCOBALAMINE [57 Co] GE Healthcare, gélule Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

cyanocobalamine [57 co] ge healthcare, gélule

ge healthcare sas - cyanocobalamine (57co) - gélule - 18,5 kbq à la date de calibration - composition pour une gélule > cyanocobalamine (57co) : 18,5 kbq à la date de calibration - produit radiopharmaceutique à usage diagnostique

OLIGOSTIM COBALT, comprimé sublingual Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

oligostim cobalt, comprimé sublingual

laboratoire des granions - cobalt 0 - comprimé - 0,029 mg - pour un comprimé > cobalt 0,029 mg sous forme de : gluconate de cobalt 0,240 mg - oligotherapie (v : divers). - classe pharmacothérapeutique : oligotherapie (v : divers)ce médicament est utilisé chez l'adulte comme modificateur du terrain en particulier au cours d'états migraineux.

OLIGOSTIM ZINC NICKEL COBALT, comprimé Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

oligostim zinc nickel cobalt, comprimé

laboratoire des granions - cobalt - comprimé - 0,029 mg - composition pour un comprimé > cobalt : 0,029 mg . sous forme de : cobalt (gluconate de) 0,240 mg > nickel : 0,029 mg . sous forme de : nickel (gluconate de) 0,220 mg > zinc : 0,032 mg . sous forme de : zinc (gluconate de) 0,220 mg

GUDAIR EMULSION INYECTABLE PARA OVINO Y CAPRINO # GUDAIR EMULSIÓN INYECTABLE PARA OVINO Y CAPRINO Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

gudair emulsion inyectable para ovino y caprino # gudair emulsión inyectable para ovino y caprino

cz vaccines s.a.u. - mycobacterium paratuberculosis, inactivado cepa 316f - emulsiÓn inyectable - mycobacterium paratuberculosis, inactivado cepa 316f 2 mm - mycobacterium - ovino; caprino

Mycobacterium bovis comp D13 Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

mycobacterium bovis comp d13

steinberg pharma ag - mycobacterium bovis, d13, 50.0 %; mycobacterium bovis, d13, 50.0 % - d - mycobacterium bovis, d13, 50.0 %; mycobacterium bovis, d13, 50.0 % - homöopathisch

Mycobacterium bovis comp D9 Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

mycobacterium bovis comp d9

steinberg pharma ag - mycobacterium bovis, d9, 50.0 %; mycobacterium bovis, d9, 50.0 % - b - mycobacterium bovis, d9, de 50,0 %; mycobacterium bovis, d9, de 50,0 % - homöopathisch